Related Experiment Video
Updated: Jan 3, 2026

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.3K
A Virtual Type 2 Diabetes Clinic Using Continuous Glucose Monitoring and Endocrinology Visits
Ronald F Dixon1, Howard Zisser2, Jennifer E Layne1
1Onduo LLC, Newton, MA, USA.
Journal of Diabetes Science and Technology
|November 26, 2019
Summary
The Onduo Virtual Diabetes Clinic (VDC) improved type 2 diabetes (T2D) management. This telehealth model, combining devices and coaching, significantly lowered HbA1c levels in participants not meeting treatment targets.
Area of Science:
- Digital Health
- Endocrinology
- Diabetes Management
Background:
- Type 2 diabetes (T2D) requires continuous management.
- Traditional care models face challenges in sustained patient engagement.
- Telehealth offers a promising avenue for improving diabetes care accessibility.
Purpose of the Study:
- To evaluate the effectiveness of the Onduo Virtual Diabetes Clinic (VDC) telehealth model for adults with T2D.
- To assess the impact of the VDC on glycemic control (HbA1c) in T2D patients.
- To explore the role of connected devices, remote coaching, and specialist consultations in T2D management.
Main Methods:
- The VDC integrates connected devices, remote lifestyle coaching, and clinical support via a mobile app.
- Key features include live video consultations with endocrinologists and real-time continuous glucose monitoring (CGM) for high-risk individuals.
- Preliminary data analyzed from 740 participants with T2D.
Main Results:
- Participation in the VDC was associated with significant HbA1c improvements over 6 months for those not meeting treatment targets.
- HbA1c reductions observed: 2.3% (±1.9%) for baseline >9.0%, 0.7% (±1.0%) for 8.0%-9.0%, and 0.2% (±0.8%) for 7.0% to <8.0% (all P < .001).
- Significant improvements were noted across different baseline glycemic categories.
Conclusions:
- The VDC telehealth model demonstrates potential in supporting individuals with T2D and their clinicians.
- The integration of technology and personalized support can enhance diabetes management between clinical visits.
- The VDC shows promise for improving glycemic control and patient outcomes in T2D care.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
4.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K
Diabetes: Management and Pharmacotherapy
817
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
817
Diabetes Mellitus: Overview and Type I Subtype
4.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.8K
Diabetes: Symptoms, Diagnosis, and Complications
2.0K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.0K
Carbohydrate Metabolism
13.6K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
13.6K
Hypoglycemia and Glucagon
750
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
750

